BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38483049)

  • 1. Hydrochlorothiazide and increased risk of atypical fibroxanthoma and pleomorphic dermal sarcoma.
    Kuntz T; Grimm A; Hofmann SC; Michalowitz AL; Schaller J; Hellmich M; Assaf C; Oellig F; Kreuter A
    J Dtsch Dermatol Ges; 2024 Apr; 22(4):513-519. PubMed ID: 38483049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers.
    Kuntz T; Siebdrath J; Hofmann SC; Baltaci M; Schaller J; Hellmich M; von Goltzheim LS; Assaf C; Oellig F; Michalowitz AL; Helbig D; Kreuter A
    J Dtsch Dermatol Ges; 2022 Dec; 20(12):1581-1588. PubMed ID: 36442137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
    Soleymani T; Tyler Hollmig S
    Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical fibroxanthoma and pleomorphic dermal sarcoma: Is superficial infiltration in subcutaneous tissue acceptable in AFX?
    van Midden D; Flucke UE; Amir AL; Bonenkamp JJ; Lubeek SFK; Blokx WAM
    Ann Diagn Pathol; 2022 Jun; 58():151915. PubMed ID: 35276548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Nonmelanoma Skin Cancer in Association With Use of Hydrochlorothiazide-Containing Products in the United States.
    Eworuke E; Haug N; Bradley M; Cosgrove A; Zhang T; Dee EC; Adimadhyam S; Petrone A; Lee H; Woodworth T; Toh S
    JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 33733052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS).
    Helbig D; Ziemer M; Dippel E; Erdmann M; Hillen U; Leiter U; Mentzel T; Osterhoff G; Ugurel S; Utikal J; von Bubnoff D; Weishaupt C; Grabbe S
    J Dtsch Dermatol Ges; 2022 Feb; 20(2):235-243. PubMed ID: 35099104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemato-Oncological Diseases as Risk Factor for Recurrence or Metastasis of Pleomorphic Dermal Sarcoma.
    Helbig D
    Front Oncol; 2022; 12():873771. PubMed ID: 35494063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleomorphic Dermal Sarcoma: A Clinical and Histopathologic Emulator of Atypical Fibroxanthoma, but Different Biologic Behavior.
    Carletti M; Nguyen DA; Malouf P; Ingersoll Z; Hosler GA; Weis SE
    HCA Healthc J Med; 2022; 3(5):299-304. PubMed ID: 37425251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleomorphic Dermal Sarcoma.
    Saleh JS; Whittington CP; Bresler SC; Patel RM
    Surg Pathol Clin; 2024 Mar; 17(1):153-158. PubMed ID: 38278604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical fibroxanthoma and pleomorphic dermal sarcoma: Local recurrence and metastasis in a nationwide population-based cohort of 1118 patients.
    Ørholt M; Abebe K; Rasmussen LE; Aaberg FL; Lindskov LJ; Schmidt G; Wagenblast AL; Petersen MM; Loya AC; Daugaard S; Herly M; Jensen DH; Vester-Glowinski P
    J Am Acad Dermatol; 2023 Dec; 89(6):1177-1184. PubMed ID: 37634740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical fibroxanthoma and pleomorphic dermal sarcoma - gene expression analysis compared with undifferentiated cutaneous squamous cell carcinoma.
    Anders IM; Schimmelpfennig C; Wiedemann K; Löffler D; Kämpf C; Blumert C; Reiche K; Kunz M; Anderegg U; Simon JC; Ziemer M
    J Dtsch Dermatol Ges; 2023 May; 21(5):482-491. PubMed ID: 37035902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
    Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
    Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control study.
    Adalsteinsson JA; Muzumdar S; Waldman R; Hu C; Wu R; Ratner D; Ungar J; Silverberg JI; Olafsdottir GH; Kristjansson AK; Tryggvadottir L; Jonasson JG
    J Am Acad Dermatol; 2021 Mar; 84(3):669-675. PubMed ID: 32791082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical Characteristics of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: A Systematic Review and Meta-Analysis.
    Ørholt M; Abebe K; Aaberg F; Rasmussen LE; Daugaard S; Loya AC; Herly M; Vester-Glowinski PV
    Am J Dermatopathol; 2022 Dec; 44(12):913-920. PubMed ID: 36395448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical fibroxanthoma of the scalp with recurrent and multiple regional cutaneous metastases.
    Nergard J; Glener J; Reimer D; Greenwald JS
    JAAD Case Rep; 2016 Nov; 2(6):491-493. PubMed ID: 27981227
    [No Abstract]   [Full Text] [Related]  

  • 16. Does hydrochlorothiazide increase the incidence of skin, lip and oral cancer in a UK population?
    Carney K; Cousins M
    Evid Based Dent; 2022 Mar; 23(1):38-39. PubMed ID: 35338330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear cell variant of atypical fibroxanthoma and pleomorphic dermal sarcoma: Molecular characterization and review of the literature.
    Coelho-Lima J; Bruty J; Watkins J; Liu H; Price R; Stefanos N
    J Cutan Pathol; 2022 Dec; 49(12):1031-1034. PubMed ID: 35922373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleomorphic dermal sarcoma in a man with HIV: report with next-generation sequencing analysis and review of the atypical fibroxanthoma/pleomorphic dermal sarcoma spectrum.
    Chen SX; Eichenfield DZ; Orme C; Hinds B
    Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark.
    Pedersen SA; Gaist D; Schmidt SAJ; Hölmich LR; Friis S; Pottegård A
    J Am Acad Dermatol; 2018 Apr; 78(4):673-681.e9. PubMed ID: 29217346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The many faces of Atypical fibroxanthoma.
    Agaimy A
    Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.